Mar 23, 2016

Gilead, Biogen Down On Patent Rulings; Ionis, Merck, Forward Rise

Big biotechs Gilead Sciences (GILD) and Biogen (BIIB) both fell Wednesday after receiving unfavorable patent news.

Gilead, Biogen Down On Negative Patent Rulings | Stock News & Stock Market Analysis - IBD
Big biotechs Gilead Sciences and Biogen were both trading down Wednesday morning after receiving unfavorable patent news.